BioCentury
ARTICLE | Financial News

Auspherix debuts with funding from MRCF

December 4, 2013 1:17 AM UTC

Auspherix Pty. Ltd. (Sydney, Australia) debuted on Tuesday with A$1 million ($914,700) in seed funding from Australia's Medical Research Commercialization Fund (MRCF) to develop antibiotics to treat resistant bacterial diseases. The newco will in-license IP from the ithree institute at the University of Technology Sydney that covers antibiotics with undisclosed mechanisms of action that were identified at the institute. The seed funding will be used for lead optimization and preclinical development. ...